DTC Corrective Advertising Study From FDA Will Have Longer Horizon
This article was originally published in The Pink Sheet Daily
Executive Summary
In response to public comments, FDA has extended the length of time between which study participants will view a direct-to-consumer television ad for a prescription drug and be exposed to a corrective ad.